Assay Component Generation for Modular Molecular Data Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing molecular diagnostic software requires cumbersome updates and deployments to accommodate new parameters or modules for nucleic acid analysis, limiting flexibility and efficiency.
Innovation Solution
A method and device for generating assay components that include processing/analysis modules and parameter values, allowing separation from target presence/absence determining software, enabling efficient deployment and management of these components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If assay components are integrated into target presence/absence determining software, then software functionality is complete, but software complexity and difficulty of updates increases
Solution Approach 1:
The patent divides the software system into separate modules: assay components (containing processing/analysis modules and parameter values) are separated from the target presence/absence determining software. This segmentation allows each module to be independently developed, updated, and maintained, reducing overall system complexity while preserving complete functionality.
Solution Approach 2:
The patent extracts assay components (processing/analysis modules and parameter values) from the main software application. These extracted components can be independently managed and deployed, allowing updates without requiring full software reinstallation or complex coordination between modules.
2Ease of manufacture
If assay components are separated from software, then ease of deployment and updates improves, but integration complexity increases
Solution Approach 1:
The patent creates universal assay components with standardized interfaces that can be used across different software versions and configurations. The processing/analysis modules and parameter values are designed with generic structures that accommodate multiple assay types, reducing integration complexity despite separation.
Solution Approach 2:
The patent introduces standardized data structures and interfaces as intermediaries between separated assay components and the main software. These intermediaries facilitate smooth integration and communication, managing complexity through well-defined protocols rather than direct tight coupling.
3Adaptability or versatility
If software requires updates for new parameters or modules, then functionality remains current, but time and resources for deployment increase
Solution Approach 1:
The patent prepares assay components (processing/analysis modules and parameter values) in advance as independent, pre-configured units. When updates are needed, these pre-prepared components can be quickly deployed without requiring extensive on-site configuration or development work, significantly reducing deployment time while maintaining current functionality.
Data Source
AI summary
A method for generating a component for an assay is proposed. The method may include acquiring molecular diagnostic amplification data generated by using a molecular diagnostic assay for a plurality of target nucleic acid molecules, and generating the component for the assay based at least partially on the molecular diagnostic amplification data. The component may include a processing/analysis module including sub-modules for processing and analyzing, in the target presence/absence determining software, the molecular diagnostic amplification data for the plurality of target nucleic acid molecules, and a parameter value referenced by the sub-modules. A sub-module predefined to be called for the processing and analyzing the molecular diagnostic amplification data among the sub-modules may process and analyze the molecular diagnostic amplification data for the plurality of target nucleic acid molecules by referencing the parameter value in response to a request of the target presence/absence determining software.